Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rolf Oberholzer"'
Autor:
David Blum, Caroline Hertler, Rolf Oberholzer, Susanne deWolf‐Linder, Markus Joerger, Christoph Driessen, Florian Strasser
Publikováno v:
JCSM Rapid Communications, Vol 5, Iss 1, Pp 68-76 (2022)
Abstract Background Cancer cachexia (CC) impacts quality of life, physical function, anticancer treatment response, and survival. Inflammation is a prominent pathomechanism of CC. This small‐scale study sets out to investigate the immunomodulatory
Externí odkaz:
https://doaj.org/article/5fa6f6eb82c44c82a47ca0e7aebb1323
Autor:
David Blum, Susanne deWolf‐Linder, Rolf Oberholzer, Michael Brändle, Thomas Hundsberger, Florian Strasser
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 2, Pp 506-516 (2021)
Abstract Background Natural ghrelin, a peptide growth hormone secretagogue, has a therapeutic potential in cachexia. We designed a dose‐finding trial of subcutaneous natural ghrelin to improve nutritional intake (NI) in advanced cancer patients. Me
Externí odkaz:
https://doaj.org/article/cc7c74483fa440438390a1d40366da0a
Autor:
Florian Strasser, David Blum, Thomas Hundsberger, Susanne de Wolf-Linder, Michael Brändle, Rolf Oberholzer
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 2, Pp 506-516 (2021)
J Cachexia Sarcopenia Muscle
Journal of Cachexia, Sarcopenia and Muscle
J Cachexia Sarcopenia Muscle
Journal of Cachexia, Sarcopenia and Muscle
BACKGROUND Natural ghrelin, a peptide growth hormone secretagogue, has a therapeutic potential in cachexia. We designed a dose-finding trial of subcutaneous natural ghrelin to improve nutritional intake (NI) in advanced cancer patients. METHODS Advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8908b50870c543d651a8430d9188623
https://doi.org/10.5167/uzh-208504
https://doi.org/10.5167/uzh-208504
Autor:
Kim Baumann, Kenneth C. H. Fearon, Florian Strasser, Jane B. Hopkinson, Stein Kaasa, Rolf Oberholzer, Aurelius Omlin
Publikováno v:
Journal of Pain and Symptom Management. 46:77-95
Context: Cancer cachexia is debilitating and affects most patients with advanced cancer. Because treatment options are poor, the psychosocial effects of cancer cachexia always should be assessed and psychosocial support provided. Objectives: To revie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::286a3fccb95d918f2435bc398bed2e84
https://doi.org/10.1016/j.jpainsymman.2012.06.020
https://doi.org/10.1016/j.jpainsymman.2012.06.020
Publikováno v:
The Journal of Arthroplasty. 14:131-137
This study examined the clinical results and technical challenges associated with acetabular reconstruction in developmental dysplasia of the hip using the acetabular reinforcement ring with hook. We reviewed 33 consecutive reconstructions performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81d4331240a2a30bacf313c70849b7a0
https://doi.org/10.1016/s0883-5403(99)90115-8
https://doi.org/10.1016/s0883-5403(99)90115-8
Autor:
Jochen Walker, Florian Strasser, Jane B. Hopkinson, Susanne de Wolf-Linder, Hanspeter Häne, Rolf Oberholzer
Publikováno v:
Journal of pain and symptom management. 46(6)
Context: Cancer cachexia syndrome (CCS) is often accompanied by psychosocial consequences (PSC). To alleviate PSC, a systematic assessment method is required. Currently, few assessment tools are available (e.g., Functional Assessment of Anorexia/Cach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19448b7050fc67bbbbd6858eafe2937b
https://pubmed.ncbi.nlm.nih.gov/23602324
https://pubmed.ncbi.nlm.nih.gov/23602324
Autor:
Marie Ange Demoitié, Rolf Oberholzer, Joe Cohen, Marie-Claude Dubois, Amanda J. Leach, Hassan Mshinda, Ajuza Jumanne, Thomas Aebi, Marc Lievens, Nahya Salim, Salim Abdulla, Johan Vekemans, Alwisa Urassa, Francisca Machera, Terrell Carter, David Schellenberg, Tonya Villafana, Omar Juma, Said Omari, W. Ripley Ballou, Christopher Membi, Mwanjaa Shomari, Marcel Tanner, Sulende Kubhoja
BACKGROUND: The RTS,S/AS malaria vaccine is being developed for delivery through the World Health Organization's Expanded Program on Immunization (EPI). We assessed the feasibility of integrating RTS,S/AS02D into a standard EPI schedule for infants.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c0ba08cd65ebd657ae2842b87734e3